- 09 Nov '22 at 10:40 pm #47381TradersComKeymaster
Solid tumor biotech Intensity Therapeutics postpones $10 million IPO
November 9, 2022
Intensity Therapeutics, a Phase 2 biotech developing intratumoral injection therapies for cancer, postponed its IPO on Wednesday. It had most recently filed in September to raise $10 million by offering 2.2 million shares at a price range of $4 to $5.
Intensity Therapeutics originally filed for an IPO in October 2021, setting terms the following November to raise $15 million by offering 1.5 million shares at a price range of $9 to $11. The company revised the terms in December, planning to raise the same amount by offering 2.1 million shares at a range of $6 to $8. This past April, it filed a new blank prospectus and disclosed that it planned to offer units with warrants attached, but removed the warrants when it set new terms in September.
The Westport, CT-based company was founded in 2012 and had planned to list on the Nasdaq under the symbol INTS. Roth Capital and The Benchmark Company were set to be the joint bookrunners on the deal.09 Nov '22 at 10:41 pm #47382TradersComKeymaster
Online game developer Snail prices IPO at $5, the midpoint of the downwardly revised range
November 9, 2022
Snail, a developer and publisher of online multiplayer games for various platforms, raised $15 million by offering 3 million shares at $5, within the range of $4 to $6. The company originally planned to offer 5 million shares at a range of $5 to $7 before lowering the terms last month.
Snail is an independent developer and publisher of interactive digital entertainment, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PCs, and mobile devices. The company states that its flagship franchise, ARK: Survival Evolved, is a leader within the sandbox survival genre with over 76.9 million console and PC installs through June 30, 2022. Its top operators by leased acreage include EQT, Antero Resources, Southwestern Energy, CNX, Ascent Resources, Encino, and Gulfport Energy.
Snail plans to list on the Nasdaq under the symbol SNAL. Tiger Brokers and EF Hutton acted as joint bookrunners on the deal.11 Nov '22 at 7:19 pm #47186Super HarleyParticipant
There is just one small deal scheduled to price, Nano-cap BullFrog AI Holdings (BFAI) is developing an analytical AI/ML platform for drug development.
[See the full post at: US Weekly IPO and SPAC Monitor: BullFrog AI and Acrivon Therapeutics]
- You must be logged in to reply to this topic.